Announcements Trials
Browse Landscape

Phase

Phase 1 38Phase 1/2 15Phase 2 7Phase EARLY_PHASE1 3Phase NA 2

Status

Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 45Gastrointestinal 12Breast 11Thoracic 9Sarcoma 6Genitourinary 6Other solid neoplasm 3CNS 3Head & Neck 2Dermatologic 2Endocrine 1

Conditions

Solid Tumor 31Advanced Solid Tumors 12Advanced Solid Tumor 8Solid Tumors 7Mesothelioma 5Retinoblastoma 3Ovarian Neoplasms 3Hematopoietic and Lymphoid System Neoplasm 3TCR-T Cells 2Solid Tumor Malignancies 2Metastatic Solid Tumors (Any Localization) 2Mesothelioma, Malignant 2Malignant Solid Tumor 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Advanced Malignant Solid Tumor 2Unspecified Adult Solid Tumor, Protocol Specific 1Unresectable or Metastatic Advanced Solid Tumors 1Stomach Neoplasms 1Solid Tumor, Adult 1Sleep Apnea, Obstructive 1Sarcoma 1Rhinitis, Allergic, Seasonal 1Rhabdomyosarcoma 1Refractory Solid Tumors 1Recurrence 1Rectal Neoplasms 1Pulmonary Fibrosis 1Pulmonary Embolism 1Pulmonary Disease, Chronic Obstructive 1

Interventions

sodium thiosulfate 1amatuximab 1X-Rays 1Specimen Handling 1Platinum 1Magnetic Resonance Spectroscopy 1Hyperthermic Intraperitoneal Chemotherapy 1Doxorubicin 1Cytoreduction Surgical Procedures 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Ovarian Neoplasms × Other solid neoplasm × Clear all
NCT07420010 2026-02-19

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

Zhejiang University

Phase EARLY_PHASE1 Not yet recruiting
24 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Colonic Neoplasms, Mesothelioma, Ovarian Neoplasms

NCT04213794 2025-02-20

TOASTIT

Mayo Clinic

Phase EARLY_PHASE1 Terminated
2 enrolled
GastrointestinalGynecologicOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Colonic Neoplasms, Fallopian Tube Neoplasms, Liposarcoma, Ovarian Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Rhabdomyosarcoma, Sarcoma, Stomach Neoplasms, Desmoplastic Small Round Cell Tumor

NCT01413451 2019-12-17

Amatuximab for High Mesothelin Cancers

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Terminated
7 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Ovarian Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡